Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Disease Management Apps Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The market size for disease management applications has experienced rapid expansion in recent years. This market is forecasted to grow from $13.05 billion in 2025 to $14.75 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 13.0%. The expansion observed during the past period is attributable to the increasing prevalence of chronic diseases, a surge in smartphone penetration, the rising acceptance of digital health solutions, the demand for continuous patient monitoring, and the broadening of telehealth services.
The disease management apps market is poised for significant expansion in the coming years. It is projected to grow to $24.18 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 13.2%. This growth during the forecast period can be attributed to advancements in AI-based health analytics, the integration of wearable health devices, a heightened focus on preventive healthcare, the increasing acceptance of remote care models, and rising initiatives for healthcare cost optimization. Major trends anticipated in this period include the integration of remote patient monitoring, personalized disease care pathways, optimized medication adherence, real-time health data analytics, and wearable-enabled chronic care management.
Get A Free Sample Report With In-Depth Market Insights:
Disease Management Apps Market Expansion Drivers: What’s Shaping Future Growth?
The expanding occurrence of chronic health issues is projected to drive the growth of the disease management apps market moving forward. Chronic conditions, defined as persistent medical ailments lasting three months or more, are effectively addressed by disease management apps. These applications offer essential tools for patients with chronic diseases, enabling them to track symptoms, record medication intake, monitor vital signs, and pinpoint triggers. A notable illustration of this trend comes from June 2024, when the National Health Service, a UK-based government department, reported that 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes—a state characterized by elevated blood sugar levels insufficient for a diabetes classification—in 2023. This figure represented an 18% surge from 3,065,825 cases recorded in 2022. Consequently, the increasing prevalence of chronic conditions is a key factor propelling the expansion of the disease management apps market.
Disease Management Apps Market Segment Analysis: What Are The Core Market Categories?
The disease management apps market covered in this report is segmented –
1) By Platform Type: iOS, Android, Other Platform Types
2) By Device: Smartphones, Tablets, Wearables
3) By Indication: Obesity, Cardiovascular Issues, Mental Health, Diabetes, Other Indications
Subsegments:
1) By iOS: IPhone Apps, iPad Apps
2) By Android: Smartphone Apps, Tablet Apps
3) By Other Platform Types: Windows Mobile Apps, Web-Based Apps
Disease Management Apps Market Strategic Trends: What Defines The Next Growth Phase?
Major companies operating in the disease management apps market are concentrating on technological breakthroughs such as GenAI to elevate their profitability within the sector. GenAI is an artificial intelligence technology that allows for the automated generation of clinical summary reports and strengthens communication between patients and healthcare providers. For instance, in August 2023, Huma Therapeutics, a UK-based healthcare technology company, unveiled its GenAI artificial intelligence (AI) disease management platform technology, leveraging Google Cloud. This cutting-edge technology is specifically crafted to integrate into its disease-management platform, aiming to enhance the decision-making instruments for diagnostic treatment and recommendations.
Disease Management Apps Market Top Companies Driving Competitive Growth
Major companies operating in the disease management apps market are Alphabet Inc.; International Business Machines Corporation; Siemens Healthineers AG; Koninklijke Philips N.V.; Garmin International Inc.; DexCom Inc.; Epic Systems Corporation; Teladoc Inc.; Fitbit LLC; athenahealth Inc.; Allscripts Healthcare Solutions Inc.; Omada Health Inc.; Calm.com Inc.; Livongo Health Inc.; American Well Corporation; MyFitnessPal Inc.; Talkspace Inc.; Noom Inc.; Ada Health GmbH; Healthy.io Ltd.; Medisafe International LLC; Sleep Cycle AB; Buoy Health Inc.; Azumio Inc.; Propeller Health Inc.; Welldoc Inc.; Informed Data Systems Inc.; Curable Inc.
View The Full Disease Management Apps Market Report:
Disease Management Apps Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the disease management apps market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the disease management apps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
